✦ LIBER ✦

Adjuvant immunotherapy of malignant melanoma

✍ Scribed by Gerard V. Aranha; Charles F. McKhann; Theodor B. Grage; Audolfur Gunnarsson; Richard L. Simmons

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 561 KB
Volume: 43
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197904)43:4<1297::aid-cncr2820430417>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of adjuvant immunotherapy to pre

Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients

✍ Gary A. Grooms; Frederick R. Eilber; Donald L. Morton 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

## Abstract A review of our experience using BCG immunotherapy as a postsurgical adjunct in the treatment of melanoma shows that the incidence of systemic metastases appears to have been reduced. However, central nervous system (CNS) metastases continue to develop in these patients and represent th

Adjuvant immunotherapy for melanoma

✍ L. J. Humphrey; S. Taschler-Collins; P. M. Coldfarb; O. Sincla; F. J. Volenec 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Adjuvant immunotherapy was administered to 84 lymph-node-negative and 25 lymph-node-positive melanoma patients. This active specific homologous cell protein preparation was given after aggressive surgery and given over 2 years. Projected and observed survival rates are presented as well as other cli

Adjuvant immunotherapy with BCG in stage

Adjuvant immunotherapy with BCG in stage II malignant melanoma

✍ M. J. Byrne; G. van Hazel; P. M. Reynolds; W. M. Lemish; C. D. J. Holman 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract Forty‐one patients were treated with BCG immunotherapy following block dissection of lymph nodes involved with malignant melanoma. A control group of similar patients who received no immunotherapy was drawn from a population consisting of all patients with malignant melanoma diagnosed i

Corynebacterium parvum versus BCG adjuva

Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma

✍ Allan Lipton; Harold A. Harvey; Bellarmine Lawrence; Robert Gottlieb; Miodrag Ku 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 1 views

Adjuvant Immunotherapy for patients with

Adjuvant Immunotherapy for patients with melanoma

✍ Jeffrey N. Myers 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Adjuvant immunotherapy in melanoma: A ne

Adjuvant immunotherapy in melanoma: A new approach

✍ E. George Elias; Vesna J. Tomazic; Barbara S. Buda 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

Patients with metastatic cutaneous melanoma to two or more regional lymph nodes have an extremely poor prognosis despite radical lymphadenectomy. In an attempt to improve the survival and to determine the safety of a new method of tumor specific adjuvant immunotherapy in such a high risk group of pa